100 related articles for article (PubMed ID: 4075321)
1. Phase II study of mitomycin in disseminated malignant melanoma.
Creagan ET; Edmonson JH; Ahmann DL; Chang M
Cancer Treat Rep; 1985 Dec; 69(12):1451-2. PubMed ID: 4075321
[No Abstract] [Full Text] [Related]
2. Phase II evaluation of spirogermanium in malignant melanoma: a Southwest Oncology Group Study.
Goodwin JW; Kopecky K; Slavik M; Tranum BL; Balcerzak SP; Fletcher WS; Costanzi JJ
Cancer Treat Rep; 1987 Oct; 71(10):985-6. PubMed ID: 3652061
[No Abstract] [Full Text] [Related]
3. Phase II study of mitolactol in advanced malignant melanoma.
Murray N; Silver H; Shah A; Wilson K
Cancer Treat Rep; 1985 Jun; 69(6):723-4. PubMed ID: 4016778
[No Abstract] [Full Text] [Related]
4. Treatment of malignant melanoma by intravascular 4-hydroxyanisole.
Morgan BD; O'Neill T; Dewey DL; Galpine AR; Riley PA
Clin Oncol; 1981 Sep; 7(3):227-34. PubMed ID: 7343168
[No Abstract] [Full Text] [Related]
5. Phase II trial of 4'-epi-doxorubicin in patients with advanced malignant melanoma.
Berman E; Casper ES; Howard J; Wittes RE
Cancer Treat Rep; 1984 Apr; 68(4):679-80. PubMed ID: 6585272
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of tamoxifen in patients with metastatic malignant melanoma.
Telhaug R; Klepp O; Børmer O
Cancer Treat Rep; 1982 Jun; 66(6):1437. PubMed ID: 7083247
[No Abstract] [Full Text] [Related]
7. Phase II study of maytansine and chlorozotocin in patients with disseminated malignant melanoma.
Ahmann DL; Frytak S; Kvols LK; Hahn RG; Edmonson JH; Bisel HF; Creagan ET
Cancer Treat Rep; 1980; 64(4-5):721-3. PubMed ID: 6448689
[No Abstract] [Full Text] [Related]
8. Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.
Lopez M; Di Lauro L; Papaldo P; Ganzina F; Di Pietro N; Lazzaro B
Cancer Treat Rep; 1986 Jul; 70(7):911-2. PubMed ID: 3459575
[No Abstract] [Full Text] [Related]
9. Phase II study of an aziridinylbenzoquinone (AZQ) in disseminated malignant melanoma.
Creagan ET; Schutt AJ; Ahmann DL; Green SJ
Cancer Treat Rep; 1982 Dec; 66(12):2089-90. PubMed ID: 7139650
[TBL] [Abstract][Full Text] [Related]
10. [Medroxyprogesterone therapy of disseminated malignant melanoma].
Rolski J; Pawlicki M
Przegl Dermatol; 1987; 74(4-5):352-7. PubMed ID: 3449906
[No Abstract] [Full Text] [Related]
11. Phase II trial of tamoxifen in malignant melanoma.
Leichman CG; Samson MK; Baker LH
Cancer Treat Rep; 1982 Jun; 66(6):1447. PubMed ID: 7083248
[No Abstract] [Full Text] [Related]
12. Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma.
Nieboer P; Mulder NH; Van Der Graaf WT; Willemse PH; Hospers GA
Anticancer Res; 2001; 21(4B):3115-6. PubMed ID: 11712820
[TBL] [Abstract][Full Text] [Related]
13. Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma.
Mayol XF; Beltran J; Rubio-Bazan R; Rifa J; Costa RR; Lopez JJ
Cancer Treat Rep; 1984 Sep; 68(9):1199-200. PubMed ID: 6444204
[No Abstract] [Full Text] [Related]
14. Phase II study of i.v. menogaril in patients with malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group Study.
McCulloch PB; Eisenhauer EA; Shibata HR; Young VP
Cancer Treat Rep; 1987; 71(7-8):771-2. PubMed ID: 2955887
[No Abstract] [Full Text] [Related]
15. Phase II trial of mitomycin in malignant mesothelioma.
Bajorin D; Kelsen D; Mintzer DM
Cancer Treat Rep; 1987 Sep; 71(9):857-8. PubMed ID: 3621220
[No Abstract] [Full Text] [Related]
16. Cis-diamminedichloroplatinum in the treatment of disseminated malignant melanoma.
Mechl Z; Krejcí P
Neoplasma; 1983; 30(3):371-7. PubMed ID: 6683360
[TBL] [Abstract][Full Text] [Related]
17. Mitoxantrone in malignant melanoma.
Presant CA; Gams R; Bartolucci A
Cancer Treat Rep; 1984 Jun; 68(6):903-5. PubMed ID: 6733704
[TBL] [Abstract][Full Text] [Related]
18. A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
Whitehead RP; Moon J; McCachren SS; Hersh EM; Samlowski WE; Beck JT; Tchekmedyian NS; Sondak VK;
Cancer; 2004 Apr; 100(8):1699-704. PubMed ID: 15073859
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
Creagan ET; Ahmann DL; Schutt AJ; Green SJ
Cancer Treat Rep; 1982 Jun; 66(6):1425-6. PubMed ID: 7083244
[TBL] [Abstract][Full Text] [Related]
20. Protracted vinblastine infusion. Phase I-II study in malignant melanoma and other tumors.
Lokich JJ; Zipoli TE; Perri J; Bothe A
Am J Clin Oncol; 1984 Oct; 7(5):551-3. PubMed ID: 6507377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
